Safety and efficacy study of botulinum toxin type A for the treatment of neurogenic overactive bladder

Title
Safety and efficacy study of botulinum toxin type A for the treatment of neurogenic overactive bladder

Type of intervention
Drug

Form of MS
All

Brief summary
Randomised, double-blind, parrallel-group trial of the safety and efficacy of botulinum toxin for urinary incontinence as a result of spinal cord injury or multiple sclerosis

Inclusion criteria

• Urinary incontinence as a result of neurogenic overactive bladder due to spinal cord injury or multiple sclerosis
• Inadequate response to anticholinergic medication used to treat overactive bladder
• Neurological respiratory impairment and abnormal pulmonary function test results

Anticipated start date

Recruitment status
Closed

Recruitment contacts
clinicaltrials@allergan.com

Further details
http://clinicaltrials.gov/ct2/show/NCT00439140?term=multiple+sclerosis&recr=Open&cntry1=PA%3AAU&rank=10

Region
QLD

Trial results

Last updated: May 2011